Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 830.65
-6.75 (-0.81%)
At close: Jul 13, 2026
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 163.35 billion as of July 13, 2026. Its market cap has decreased by -11.09% in one year.
Market Cap
163.35B
Enterprise Value
175.57B
Revenue
73.45B
Ranking
n/a
PE Ratio
24.21
Stock Price
830.65
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 163.35B, an increase of 1,714.71%. That is a compound annual growth rate of 21.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 163.35B | -1.78% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 235.82B |
| Granules India | 220.43B |
| AstraZeneca Pharma India | 203.10B |
| Caplin Point Laboratories | 196.52B |
| Jubilant Pharmova | 152.20B |
| CORONA Remedies | 124.94B |
| Viyash Scientific | 121.49B |